O'Brien Ronan 4
4 · Pear Therapeutics, Inc. · Filed Jan 18, 2023
Insider Transaction Report
Form 4
O'Brien Ronan
General Counsel & Secretary
Transactions
- Exercise/Conversion
Common Stock
2023-01-14+30,800→ 30,800 total - Exercise/Conversion
Restricted Stock Units
2023-01-14−30,800→ 62,533 total→ Common Stock (30,800 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
- [F2]The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025.